Unlike conventional diagnostics that focus solely on identifying pathogens, TriVerity delivers three integrated host-response scores—bacterial infection, viral infection, and illness severity—from a ...
SUNNYVALE, Calif., Jan. 21, 2025 /PRNewswire/ -- Inflammatix, a pioneering host response diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing ...
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) purchases TriVerity Test System to evaluate for use in the field Inflammatix receives an ...
First Interventional Study Designed to Demonstrate the Clinical Utility of the TriVerity Test and its Impact on Patient Management "As the first interventional study to demonstrate the clinical ...
Just a few weeks later than expected, Inflammatix Inc. secured U.S. FDA clearance of the Triverity test system for use in emergency triage of patients with suspected acute infection or sepsis. The ...
Microscopy image showing red blood cells and bacteria caught in a web of fibrin threads. Composite colored scanning electron micrograph of sepsis blood clotting. The clots can damage or destroy tissue ...
SUNNYVALE, Calif., Jan. 21, 2025 /PRNewswire/ -- Inflammatix, a pioneering host response diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing ...
SUNNYVALE, Calif., Aug. 4, 2025 /PRNewswire/ -- Inflammatix, a leader in host-response diagnostics, today announced that its TriVerity™ Test has been granted New Technology Add-On Payment (NTAP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results